Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsAEISAdvanced Energy Industries Upgraded byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$121.34+3.5% $140.00Neutral ➝ BuyAMBAAmbarella Upgraded byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$74.78+3.1% $80.00Underperform ➝ NeutralAMEAMETEK Upgraded byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$189.64+1.2%$195.00 ➝ $225.00Neutral ➝ BuyBMABanco Macro Upgraded byMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating$104.69+12.6% $12.50Underweight ➝ OverweightBMYBristol-Myers Squibb Upgraded byJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$56.22+0.8%$63.00 ➝ $70.00Hold ➝ BuyBTUPeabody Energy Upgraded byBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.72-1.3%$26.00 ➝ $26.00Market Perform ➝ OutperformBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free GuideCBRECBRE Group Upgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$139.44+1.6%$120.00 ➝ $163.00Neutral ➝ OverweightCONConcentra Group Holdings Parent Upgraded byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.63+5.5% $24.00Neutral ➝ BuyCOPConocoPhillips Upgraded byMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating$100.55-0.5%$132.00 ➝ $134.00Neutral ➝ OutperformCRKComstock Resources Upgraded byMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating$16.34-2.7%$10.00 ➝ $18.00Underperform ➝ NeutralDNLIDenali Therapeutics Upgraded byStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating$23.99+4.4% $37.00Hold ➝ BuyEFXEquifax Upgraded byBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. GroblerSubscribe to MarketBeat All Access for the recommendation accuracy rating$272.84+2.6% $305.00Neutral ➝ OutperformEQTEQT Upgraded byMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating$44.90-1.5%$48.00 ➝ $57.00Neutral ➝ OutperformEWEdwards Lifesciences Upgraded byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$73.12-0.3%$82.00 ➝ $90.00Neutral ➝ BuyGGALGrupo Financiero Galicia Upgraded byMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating$67.15+7.8% $92.00Underweight ➝ OverweightKEYSKeysight Technologies Upgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$170.12+2.2%$170.00 ➝ $200.00Neutral ➝ OverweightLFSTLifeStance Health Group Upgraded byThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.69+7.3% $10.00Neutral ➝ BuyMMacy's Upgraded byGordon HaskettSubscribe to MarketBeat All Access for the recommendation accuracy rating$17.12+3.4% $20.00Hold ➝ BuyNTAPNetApp Upgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$124.96+2.5% $160.00Neutral ➝ OverweightOKTAOkta Upgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$83.81+2.2% $100.00Neutral ➝ OverweightTAT&T Upgraded byMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating$23.04-2.5%$19.00 ➝ $28.00Equal Weight ➝ OverweightTERTeradyne Upgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$128.99+4.7%$145.00 ➝ $158.00Neutral ➝ OverweightTRMBTrimble Upgraded byWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating$74.38+1.1% $90.00Peer Perform ➝ OutperformUSPHU.S. Physical Therapy Upgraded byBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating$97.26+4.1%$100.00 ➝ $115.00Neutral ➝ BuyZYMEZymeworks Upgraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating$13.92+10.7% $18.00Neutral ➝ OverweightAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:47 AM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
